Sanofi SA (SNY)
47.98
+0.20
(+0.42%)
USD |
NASDAQ |
Nov 21, 16:00
48.05
+0.07
(+0.15%)
Pre-Market: 09:20
Sanofi Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 60.84B |
| December 31, 2023 | 57.60B |
| June 30, 2023 | 56.95B |
| December 31, 2022 | 55.30B |
| June 30, 2022 | 52.77B |
| December 31, 2021 | 57.98B |
| June 30, 2021 | 58.26B |
| June 30, 2020 | 58.86B |
| December 31, 2019 | 59.82B |
| June 30, 2019 | 61.43B |
| December 31, 2018 | 59.91B |
| June 30, 2018 | 65.23B |
| December 31, 2017 | 49.88B |
| December 31, 2016 | 49.64B |
| December 31, 2015 | 48.23B |
| June 30, 2015 | 46.15B |
| December 31, 2014 | 50.01B |
| June 30, 2014 | 53.14B |
| December 31, 2013 | 53.88B |
| June 30, 2013 | 53.16B |
| December 31, 2012 | 56.75B |
| Date | Value |
|---|---|
| June 30, 2012 | 56.47B |
| December 31, 2011 | 57.39B |
| June 30, 2011 | 68.03B |
| December 31, 2010 | 42.53B |
| June 30, 2010 | 41.17B |
| December 31, 2009 | 45.29B |
| June 30, 2009 | 44.88B |
| December 31, 2008 | 37.61B |
| June 30, 2008 | 41.04B |
| December 31, 2007 | 39.69B |
| June 30, 2007 | 39.19B |
| December 31, 2006 | 42.14B |
| June 30, 2006 | 46.59B |
| December 31, 2005 | 48.06B |
| June 30, 2005 | 53.90B |
| December 31, 2004 | 59.48B |
| June 30, 2004 | 4.512B |
| December 31, 2003 | 4.281B |
| June 30, 2003 | 3.711B |
| December 31, 2002 | 3.577B |
| June 30, 2002 | 3.487B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
52.77B
Minimum
Jun 2022
60.84B
Maximum
Jun 2024
57.60B
Average
57.98B
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 64.12B |
| GSK PLC | 59.68B |
| Eli Lilly and Co | 61.29B |
| Novavax Inc | 2.239B |
| Regeneron Pharmaceuticals Inc | 8.116B |
Total Liabilities (Quarterly) Related Metrics
| Net Debt Paydown Yield | 2.85% |